All Type of News
Yuyu Pharm wins EU patent for its ticlopidine plus ginkgo biloba extract patent
Yuyu Pharm says it has recently won from European Union a patent relating to a novel pharmaceutical composition containing ticlopidine and ginkgo biloba extract after acquisition of Korea and US patents.
Ticlopidin...
Low-priced printing machines attract local pharmaceutical firms
With the government plan to implement the drug's identification system by dosage form for better safety of drugs sooner or later, more and more local printing machine manufactures and importers would likely jump into ...
Green Cross to feast children's day with families and children.
Green Cross invited all families of the company employees to the office for the feast of "Children's day" and "the Month of Family".
Green Cross took this kind of feast in May every year since 2001 but this year th...
Forum for how to promote Health Functional Food Industry.
Korea Health Industry Development Institute (KHIDI) (President: Lee Kyeong-ho) will have a health industry promotional forum at the auditorium at 3 p.m. on May 10 under the title of "How to promote the health function...
Il Dong celebrated the 63th anniversary of company inauguration.
Il Dong Pharmaceutical Co. (CEO: Lee Kum-ki) took the 63 anniversary ceremony of the company inauguration at the company auditorium on May 4, thereby ensuring this year's target to fulfil for leaping up to be of the s...
Prevalence of asthma increasing in East Asia and Pacific region
According to a report released on May 4, World Asthma Day 2004, asthma has become more common throughout East Asia and the Pacific region in recent decades and affected about 300 million people worldwide.
The Globa...
Bioequivalence tests to be stimulated
The Korea Food and Drug Administration says that in-house undertakings of bioequivalence tests by pharmaceutical firms will be stimulated by the policy of the administration to conduct its commissioned standard bioequ...
EC approves Velcade for multiple myeloma treatment
The European Commission issued on April 27 a positive decision for Velcade (bortezomib) injection, a new treatment for multiple myeloma, a form of blood cancer.
A single license has been granted to market Velcade ...
KFDA concerned inadequate manpower.
The Drug Safety department of KFDA Drug Safety Bureau faced difficulty in full work performances mainly due to a short of manpower. The Department organized with the total 6 administrative officers had to dispatch 2 o...
KFDA to oppose quality certification policy on herbal drugs.
KFDA took a tough position against the herbal drug quality certification by Herbal Drug Promotion Foundation as specified in the draft of the enforcement decree of the Herbal Drug Fostering Act, claiming that it be a ...
